Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane in Subjective Tinnitus
NCT00772980Phase 3Completed
- Sponsor
- Merz
- Start
- Nov 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of neramexane in tinnitus, sponsored by Merz. Started Nov 2008; status: completed.
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT00772980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772980.